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The Coronavirus Disease 2019 (COVID-19) is a new viral infection caused by the severe acute respiratory coronavirus 2
(SARS-CoV-2). Genomic analyses have revealed that SARS-CoV-2 is related to Pangolin and Bat coronaviruses. In this report, a
structural comparison between the Sars-CoV-2 Envelope and Membrane proteins from different human isolates with
homologous proteins from closely related viruses is described. The analyses here reported show the high structural similarity of
Envelope and Membrane proteins to the counterparts from Pangolin and Bat coronavirus isolates. However, the comparisons
have also highlighted structural differences specific of Sars-CoV-2 proteins which may be correlated to the cross-species
transmission and/or to the properties of the virus. Structural modelling has been applied to map the variant sites onto the
predicted three-dimensional structure of the Envelope and Membrane proteins.
1. Introduction
COVID-19 has become a planetary emergency which is
seriously threatening human health [1, 2]. Development of
effective therapeutic and prevention strategies is significantly
hampered also by the lack of detailed structural information
on virus proteins, although several crystallographic struc-
tures of Sars-CoV-2 proteins are now available [3–5]. In this
report, a structural comparison between the Sars-CoV-2
surface proteins from different isolates with homologous
proteins from closely related viruses such as those from Bat
and Pangolin is described. This work has been focussed onto
the Envelope (E) and Membrane (M) proteins that, along
with the Spike, form the virus protein interface to the exter-
nal environment. The Spike glycoprotein has been already
extensively studied, and a few crystallographic structures
are available in the Protein Data Bank [3–6]; consequently,
this protein has not been specifically addressed within
this note. Identification of local structural differences, even
minimal, to the closest virus proteins may indicate the muta-
tions that enabled Sars-CoV-2 to cross species and/or to
acquire its peculiar pathogenic properties [7, 8]. Indeed, a
number of examples have been reported in the scientific liter-
ature suggesting how even single point mutations in virus
proteins can significantly alter their biology and pathogenesis
[9, 10]. Therefore, comparative studies may shed light on
the molecular mechanisms through which an epidemic of
epizootic origin can emerge and may also suggest molecular
targets for therapeutics or reverse vaccinology experiments.
2. Material and Methods
Nucleotide and protein sequences have been taken from
GenBank [11] data repository. Blast suite [12] has been used
for databank searches; Jalview [13] and MAFFT [14] have
been used for multiple sequence display and alignment,
respectively. Transmembrane helix prediction has been
obtained by TMHMM [15], MEMSAT [16], and Protter
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[17]. Cd-hit program [18] has been used for sequence clus-
tering. Homology modelling relied on Swiss-Model [19],
Modeller [20], or HHpred [21] and structure display and
analysis on Open-Source PyMOL [22]. When necessary,
I-Tasser [23] has been used as an alternative source of ab
initio homology models.
3. Results
3.1. Databank Searches and Structure Modelling. From the
GenBank repository, 797 complete genomes of Sars-CoV-2
have been collected (the full list is reported in Supplementary
Data). The TblastN program has been used to extract the
sequences of E and M proteins from each genome. To
remove redundancy within each E and M protein set, cd-hit
clustering has been applied at 100% sequence identity level:
identical sequences have been assigned to the same group
for which only one representative has been considered for
further analysis. The Sars-CoV-2 E and M protein sets have
been grouped into three and seven clusters, respectively. This
finding suggests that within the 797 genomes three and seven
variants of the E and M proteins can be observed, respec-
tively. E and M homologous proteins from closely related
virus have been retrieved from the GenBank using the
TblastN tool.
3.2. Envelope Protein. The E protein is conserved across
β-coronaviruses. Only three variants have been found in
the Sars-CoV-2 E set collected. Sequence comparisons show
that the Sars-CoV-2 E protein from the reference genome
(RefSeq code YP_009724392) is identical to the sequences
from Pangolin CoV MP798 and Bat CoV CoVZXC21,
CoVZC45, and RaTG13 isolates. The multiple sequence
alignment reported in Figure 1 demonstrates that a distin-
guishing feature of Sars-2-CoV E variants is the presence of
Arg at position 69 that substitutes Glu, Gln, Asp in other
homologous Sars-CoV E proteins. This site is followed by a
deletion in position 70 corresponding to Gly or Cys in the
other proteins. Sars-CoV-2 E sequences differ from the
homologous proteins also at positions 55-56, where the dyad
Ser-Phe replaces Thr-Val (except in Bat coronavirus isolate
BtKY72, accession code KY352407). Variants of the
Sars-CoV-2 E protein differ at positions 37 and 72 where
His substitutes a Leu and Leu replaces a conserved Pro,
respectively. The size of each Envelope variant cluster is
reported in Table 1 along with accession codes and definitions
of the isolates. A homology model of the E protein has been
built with Modeller using as a template the pentameric ion
channel structure of Sars-CoV protein identified by the PDB
code 5X29. This sequence shares 91% identity to Sars-CoV-
2 E protein and covers the segment encompassed by positions
8-65. Figure 2 displays the structure of the homologymodel of
the Sars-CoV-2 E protein assembled as a pentameric
viroporin-like protein. Figure 2 displays also the position of
the variant sites onto the three-dimensionalmodel. Prediction
of the transmembrane helices is difficult in a short protein.
Therefore, transmembrane topology cannot be assigned reli-
ably. Likewise, experiments have not clarified definitively
which portions of the E protein are exposed to the external
or internal side of the virus membrane [24].
3.3. Membrane Glycoprotein. The M glycoprotein is con-
served across the β-coronaviruses. However, seven variants
of Sars-CoV-2 M protein were identified in the collected
set, while only three variants were observed for the E protein
(Figure 3). The multiple sequence alignment shows a
remarkable similarity (98% identity) among the Sars-CoV-2
M variants and the sequences from Bat and Pangolin isolates.
However, a difference at the N-terminal position (Figure 3)
can be observed: the insertion of a Ser residue at position 4
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Figure 1: Multiple sequence alignment among Sars-CoV-2 Envelope protein variants and a set of the most similar homologous proteins. The
sequence labelled Sars-CoV-2 corresponds to the reference sequence identified by the RefSeq code YP_009724392. Red lines below the
alignment indicate the changed sites discussed in the text. Blu background denotes conserved alignment positions.
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of human Sars-CoV-2 seems to be a unique feature of this
protein. In the corresponding position, the RaTG13 Bat M
protein displays a deletion, while Bat CoVZXC21, CoVZC45,
and Pangolin MP789 proteins have an Asp residue. The
seven M protein variants differ at positions 2, 3, 57, 70, 85,
89, and 175. The size of each Membrane variant cluster
is reported in Table 1 along with accession codes and defini-
tions of the isolates. Noteworthy, the protein from the Sars-
CoV-2 NIHE isolate (accession code MT127115) possesses
an Arg instead of a conserved Gly at position 89 (Figure 3).
The mutation occurs within a predicted transmembrane
helix and, if confirmed, may have a significant impact on
the protein properties (Figure 3).
The three-dimensional model of the M protein has been
taken from the I-Tasser server (code QHD43419) as other
methods failed to find any suitable template. However, it
should be mentioned that HHpred found a weak local affin-
ity, albeit below the statistical significance level, to 4N31, a
peptidase-like protein from Streptococcus pyogenes essential
for pilus polymerisation. Figure 4 displays the positions of
the variant sites onto the model structure. This model has
been predicted by ab initio techniques. Therefore, it should
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Figure 2: Three-dimensional model of the viroporin-like tetrameric assembly of the E protein from Sars-CoV-2 represented as a cartoon
model. Residues corresponding to the mutated sites indicated in Figure 1 are displayed as transparent space-filling spheres and labelled
with the amino acid one-letter code. The C-terminal segments of the model are reported for completeness. However, they convey no
structural information due to lack of a corresponding segment in the structural template used in homology modelling. Structure in panel
(b) is rotated by approximately 180° along the x axis with respect to the orientation shown in panel (a).
Table 1: Size of the variant clusters of the Sars-CoV-2 Envelope and Membrane proteins.
Variant Cluster size (no. of sequences) Accession code Definition
Envelope
YP_009724392 (reference) 795
His37 1 MT03980 Korea/SNU01/2020
Leu72 1 MT293206 USA/WA-UW-1588/2020
Membrane
YP_009724393 (reference) 773
Ser2 1 MT291836 CHN/Wuhan_IME-BJ07/2020
Gly3 1 MT325626 USA/SC_3572/2020
Val57, Arg89 1 MT127115 VIE/NIHE/2020
MT293184 USA/WA-UW-1297/2020
lle70 3 MT326166 USA/WA-UW-1735/2020
MT293211 USA/WA-UW-1591/2020
Ser85 1 MT326167 USA/WA-UW-1753/2020
MT326093 USA/WA-UW-1775/2020
Met175 2 MT246451 USA/WA-UW-194/2020
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Figure 3: Multiple sequence alignment among Sars-CoV-2M protein variants and a set of most similar homologous proteins. The sequence label
Sars-CoV-2 indicates the reference sequence identified by the RefSeq code YP_009724393. Red box indicates the variant sites at the N-terminal
discussed in the text. Numbered red bars under the multiple alignment mark the prediction of transmembrane helices. The location of the
connect loop with respect to the virion surface is indicated as “in” or “out”. Blu background denotes conserved alignment positions.
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be considered with great caution and should be treated as a
low-resolution approximation of the real structure. Accord-
ing to the prediction of the transmembrane helix topology,
the N- and C-terminal portions of the M protein are exposed
outside and inside the virus particle, respectively (Figure 4).
4. Discussion
Previous studies pointed out that E and M proteins could be
important for viral entry, replication, and particle assembly
within the human cells [24, 25]. According to the accepted
theories, the current COVID-19 pandemic has been caused
by the cross-species transmission of a β-coronavirus nor-
mally hosted by Bats and, perhaps, Pangolin to humans
[3, 26]. In this paper, E and M proteins from 797 Sars-
CoV-2 genomes have been compared to the counterparts
taken from the most closely related virus also to evaluate
the potential role of amino acid mutations in the epizootic
origin of COVID-19. E protein is a minor component of
the virus membrane though it is deemed to be important
for many stages of virus infection and replication [24, 25].
Sequence comparison has shown that this protein is identical
to the counterparts of specific Bat and Pangolin coronavirus
isolates, even though the Sars-CoV-2 sequence seems to pos-
sess specific modifications and characteristics with respect to
other Sars CoVs. In particular, Arg69, a positively charged
amino acid, replaces Glu or Gln residues, negatively charged
and neutral, respectively, in the homologous CoV proteins.
Moreover, a deletion specific to Sars-CoV-2 proteins flanks
this position. Unfortunately, it is not possible to predict reli-
ably whether the sites of these modifications are exposed to
the internal or external side of the membrane. In any case,
the substitution and the deletion appear a rather drastic
change and may have a significant impact on conformational
properties and possibly on protein-protein interactions.
Further structural studies are needed. However, it may
be hypothesized that these changes can also affect the olig-
omerization process necessary to form a transmembrane
ion channel.
It has been demonstrated that M protein is more prev-
alent within the virus membrane, and it is deemed to be
important for the budding process of coronaviruses.
Indeed, during the process of virus particle assembly, this
protein interacts with the Nucleocapsid, Envelope, Spike,
and Membrane glycoprotein itself [25]. Moreover, in
Alphacoronaviruses, it has been demonstrated that this
protein cooperates with the Spike during the cell attach-
ment and entry [27]. Therefore, mutations occurring at
the N-terminus region, which is exposed to the virus sur-
face, could play a key role in the host cell interaction.
In conclusion, the analyses here reported show the struc-
tural similarity of E and M proteins to the counterparts from
Pangolin and Bat coronavirus isolates. At the same time,
comparisons have highlighted structural differences specific
of Sars-CoV-2 proteins which may be correlated to the
cross-species transmission and/or to the properties of the
virus. Although further studies are needed, it is clear that
these amino acid variations have been important for the virus
evolutionary history, and the results may hint at how similar
mutations within the coronavirus family can lead in the next
years to other epizootic epidemic events similar to the one
that we are experiencing these days.
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spheres and labelled with the amino acid one-letter code.
5BioMed Research International
Acknowledgments
This work has been in part funded by a grant to SP from
Sapienza University of Rome (RP11916B74B27C4D).
Supplementary Materials
The supplementary data consist of an Excel file containing
the list of the 797 Sars-CoV-2 genomes retrieved from
GenBank and analysed in the article. For each genome, the
sequence header is displayed as found in the GenBank. The
header reports the accession code in the first field of each line
after the “>” character. (Supplementary Materials)
References
[1] D. Benvenuto, M. Giovanetti, A. Ciccozzi, S. Spoto,
S. Angeletti, and M. Ciccozzi, “The 2019-new coronavirus
epidemic: evidence for virus evolution,” Journal of Medical
Virology, vol. 92, no. 4, pp. 455–459, 2020.
[2] C.-C. Lai, T.-P. Shih, W.-C. Ko, H.-J. Tang, and P.-R. Hsueh,
“Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) and coronavirus Disease-2019 (COVID-19): the
epidemic and the challenges,” International Journal of Antimi-
crobial Agents, vol. 55, no. 3, article 105924, 2020.
[3] D. Benvenuto, M. Giovanetti, M. Salemi et al., “The Global
Spread of 2019-NCoV: A Molecular Evolutionary Analysis,”
Pathogens and Global Health, vol. 114, no. 2, pp. 64–67, 2020.
[4] A. C. Walls, Y.-J. Park, M. A. Tortorici, A. Wall, A. T.
McGuire, and D. Veesler, “Structure, Function, and Antigenic-
ity of the SARS-CoV-2 Spike Glycoprotein,” Cell, vol. 181,
no. 2, pp. 281–292.e6, 2020.
[5] D. Wrapp, N. Wang, K. S. Corbett et al., “Cryo-EM Structure
of the 2019-NCoV Spike in the Prefusion Conformation,”
Science, vol. 367, no. 6483, pp. 1260–1263, 2020.
[6] R. Yan, Y. Zhang, Y. Li, L. Xia, Y. Guo, and Q. Zhou,
“Structural Basis for the Recognition of SARS-CoV-2 by
Full-Length Human ACE2,” Science, vol. 367, no. 6485,
pp. 1444–1448, 2020.
[7] S. Angeletti, D. Benvenuto, M. Bianchi, M. Giovanetti,
S. Pascarella, and M. Ciccozzi, “COVID‐2019: the role of the
Nsp2 and Nsp3 in its pathogenesis,” Journal of Medical Virol-
ogy, vol. 92, no. 6, pp. 584–588, 2020.
[8] W. Ji, W. Wang, X. Zhao, J. Zai, and X. Li, “Cross‐species
transmission of the newly identified coronavirus 2019-NCoV,”
Journal of Medical Virology, vol. 92, no. 4, pp. 433–440, 2020.
[9] N. M. André, B. Cossic, E. Davies, A. D. Miller, and G. R.
Whittaker, “Distinct mutation in the feline coronavirus spike
protein cleavage activation site in a cat with feline infectious
peritonitis-associated Meningoencephalomyelitis,” Journal of
Feline Medicine and Surgery Open Reports, vol. 5, no. 1,
2019.
[10] Y. Sakai, K. Kawachi, Y. Terada, H. Omori, Y. Matsuura, and
W. Kamitani, “Two-amino acids change in the Nsp4 of SARS
coronavirus abolishes viral replication,” Virology, vol. 510,
pp. 165–174, 2017.
[11] D. A. Benson, M. Cavanaugh, K. Clark et al., “GenBank,”
Nucleic Acids Research, vol. 46, no. D1, pp. D41–D47, 2018.
[12] S. Altschul, T. L. Madden, A. A. Schäffer et al., “Gapped
BLAST and PSI-BLAST: a new generation of protein database
search programs,” Nucleic Acids Research, vol. 25, no. 17,
pp. 3389–3402, 1997.
[13] A. M. Waterhouse, J. B. Procter, D. M. A. Martin, M. Clamp,
and G. J. Barton, “Jalview version 2–a multiple sequence align-
ment editor and analysis workbench,” Bioinformatics, vol. 25,
no. 9, pp. 1189–1191, 2009.
[14] K. Katoh and D. M. Standley, “MAFFT multiple sequence
alignment software version 7: improvements in performance
and usability,” Molecular Biology and Evolution, vol. 30,
no. 4, pp. 772–780, 2013.
[15] Y. Chen, P. Yu, J. Luo, and Y. Jiang, “Secreted protein predic-
tion system combining CJ-SPHMM, TMHMM, and PSORT,”
Mammalian Genome, vol. 14, no. 12, pp. 859–865, 2003.
[16] L. J. McGuffin, K. Bryson, and D. T. Jones, “The PSIPRED
protein structure prediction server,” Bioinformatics, vol. 16,
no. 4, pp. 404-405, 2000.
[17] U. Omasits, C. H. Ahrens, S. Müller, and B. Wollscheid, “Prot-
ter: interactive protein feature visualization and integration
with experimental proteomic data,” Bioinformatics, vol. 30,
no. 6, pp. 884–886, 2014.
[18] L. Fu, B. Niu, Z. Zhu, S. Wu, and W. Li, “CD-HIT: accelerated
for clustering the next-generation sequencing data,” Bioinfor-
matics, vol. 28, no. 23, pp. 3150–3152, 2012.
[19] A. Waterhouse, M. Bertoni, S. Bienert et al., “SWISS-MODEL:
homology Modelling of protein structures and complexes,”
Nucleic Acids Research, vol. 46, no. W1, pp. W296–W303,
2018.
[20] B. Webb and A. Sali, “Protein structure modeling with MOD-
ELLER,” Methods in Molecular Biology, vol. 1654, pp. 39–54,
2017.
[21] L. Zimmermann, A. Stephens, S.-Z. Nam et al., “A completely
Reimplemented MPI bioinformatics toolkit with a new
HHpred server at its Core,” Journal of Molecular Biology,
vol. 430, no. 15, pp. 2237–2243, 2018.
[22] L. L. C. Schrodinger, The AxPyMOL Molecular Graphics
System, Version 2.0, Schrödinger, LLC., 2015.
[23] J. Yang, R. Yan, A. Roy, D. Xu, J. Poisson, and Y. Zhang, “The
I-TASSER suite: protein structure and function prediction,”
Nature Methods, vol. 12, no. 1, pp. 7-8, 2015.
[24] D. Schoeman and B. C. Fielding, “Coronavirus envelope
protein: current knowledge,” Virology Journal, vol. 16, no. 1,
p. 69, 2019.
[25] E. A. J. Alsaadi and I. M. Jones, “Membrane binding proteins
of coronaviruses,” Future Virology, vol. 14, no. 4, pp. 275–
286, 2019.
[26] R. Lu, X. Zhao, J. Li et al., “Genomic characterisation and
epidemiology of 2019 novel coronavirus: implications for virus
origins and receptor binding,” The Lancet, vol. 395, no. 10224,
pp. 565–574, 2020.
[27] A. Naskalska, A. Dabrowska, A. Szczepanski, A. Milewska,
K. P. Jasik, and K. Pyrc, “Membrane protein of human corona-
virus NL63 is responsible for interaction with the adhesion
receptor,” Journal of Virology, vol. 93, no. 19, pp. 455–459,
2019.
6 BioMed Research International
